Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

51.55 +4.39 (+9.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,934,740
Open 52.12
Bid (Size) 51.65 (15)
Ask (Size) 51.95 (14)
Prev. Close 47.16
Today's Range 49.94 - 54.71
52wk Range 39.97 - 72.83
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 15.2% in the morning session after the company reported strong first quarter 2025 results which beat analysts' revenue and... 
Via StockStory
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Via Benzinga

Performance

YTD
-9.4%
-9.4%
1 Month
+16.4%
+16.4%
3 Month
-6.7%
-6.7%
6 Month
-27.5%
-27.5%
1 Year
-16.9%
-16.9%

More News

Read More
Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
Exact Sciences to Participate in May Investor Conference
From Exact Sciences Corp.
Via Business Wire
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars
Via StockStory
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.
Via Investor's Business Daily
Topics Government
Exposures Political
Exact Sciences Announces First-Quarter 2025 Results
From Exact Sciences Corp.
Via Business Wire
Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
From Exact Sciences Corp.
Via Business Wire
2 Reasons to Like EXAS (and 1 Not So Much)
Via StockStory
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic
Via Stocktwits
Topics Government
Exposures Political
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
From Exact Sciences Corp.
Via Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
From Exact Sciences Corp.
Via Business Wire
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution
Via StockStory
Deep Dive Into Exact Sciences Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exact Sciences Schedules First Quarter 2025 Earnings Call
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
From Exact Sciences Corp.
Via Business Wire
The Future of Healthcare: 10 Predictions For The Next Decade
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 51.55
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 05/02/25 04:00 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 8.86B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.